Cargando…
Nrf2与铁死亡在肿瘤耐药中的研究进展
Lung cancer is one of the most common cancers in the world, and its treatment strategy is mainly surgery combined with radiotherapy and chemotherapy. However, long-term chemotherapy will result in drug resistance, which is also one of the difficulties in the treatment of lung cancer. Ferroptosis is...
Autores principales: | HU, Shuning, ZOU, Xinru, FANG, Yixuan, LIU, Chengrui, CHEN, Rui, JI, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663776/ https://www.ncbi.nlm.nih.gov/pubmed/37989339 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.31 |
Ejemplares similares
-
铁死亡的发生机制及其在肺癌中的研究进展
Publicado: (2020) -
RAD51AP1在肿瘤进展和耐药中的研究进展
por: LIU, Renwang, et al.
Publicado: (2023) -
铁死亡相关通路在急性髓系白血病中的研究进展
Publicado: (2023) -
STAT3在非小细胞肺癌耐药中的研究进展
Publicado: (2019) -
DNA甲基化在肺癌顺铂耐药中的研究进展
por: SUN, Jinzhe, et al.
Publicado: (2023)